home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  

registry of biomedical companies

  April 19, 2024
promoting the transfer of scientific know-how between industry and academia
Registry of biomedical companies:

[3] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 467 active entries

ProMab Biotechnologies, Inc.

5221 Central Avenue, Suite 200
Richmond, 94804
United States of America, California

Phone: 1-866-339-0871
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.


ProMab is a biotechnology company founded and managed by a team of scientists with extensive academic and industry experience. ProMab's specialty is developing and commercializing recombinant proteins and custom monoclonal antibodies the integration of bioinformatics, gene cloning, protein expression and purification, and immunology using novel high-throughput technologies. Along with its protein expression and custom antibody services, ProMab also provides a large array of products and services for cancer stem cells.  ProMab aims to be one of the leading suppliers of bio-reagents in the twenty-first century and is committed to improving human health.

For more information, and our complete product lines, please visit our website at www.promab.com, or feel free to send us an e-mail at info@promab.com.

Selected Categories:
Product Company   Service Company
- Research
- Research
- General
- Distributor
- General
- Research
- Services

Last update of this entry: January 11, 2013

home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2024 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.